Amarendra  Neppalli  to  Disease-Free Survival
                            
                            
                                This is a "connection" page, showing publications  Amarendra  Neppalli  has written about  Disease-Free Survival.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.041
         
        
        
     
 
    
        
        - 
            Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH. Am J Hematol. 2021 01; 96(1):E5-E8.
            
            
                Score: 0.041